Darwin Advisors, LLC Biogen Inc. Transaction History
Darwin Advisors, LLC
- $356 Million
- Q3 2024
A detailed history of Darwin Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Darwin Advisors, LLC holds 16 shares of BIIB stock, worth $2,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$2,280% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding BIIB
# of Institutions
993Shares Held
130MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.39 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.29 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.05 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$749 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...